Published in J Membr Biol on May 15, 1997
Effects of mitochondrial uncouplers on intracellular calcium, pH and membrane potential in rat carotid body type I cells. J Physiol (1998) 1.34
Ligand-insensitive state of cardiac ATP-sensitive K+ channels. Basis for channel opening. J Gen Physiol (1998) 1.26
Evidence for direct physical association between a K+ channel (Kir6.2) and an ATP-binding cassette protein (SUR1) which affects cellular distribution and kinetic behavior of an ATP-sensitive K+ channel. Mol Cell Biol (1998) 1.21
Infection with AV-SUR2A protects H9C2 cells against metabolic stress: a mechanism of SUR2A-mediated cytoprotection independent from the K(ATP) channel activity. Biochim Biophys Acta (2010) 0.96
Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone. Br J Pharmacol (2000) 0.82
Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol (1999) 2.87
Cardiovascular health: the global challenge. Clin Pharmacol Ther (2011) 2.52
Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proc Natl Acad Sci U S A (2001) 2.08
Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab (1999) 2.06
Signaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance. Neuron (2001) 1.92
Recombinant cardiac ATP-sensitive K+ channel subunits confer resistance to chemical hypoxia-reoxygenation injury. Circulation (1998) 1.87
Network systems biology for drug discovery. Clin Pharmacol Ther (2010) 1.69
Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Heart (2009) 1.68
ATPase activity of the sulfonylurea receptor: a catalytic function for the KATP channel complex. FASEB J (2000) 1.62
Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy. Clin Pharmacol Ther (2007) 1.60
Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc Natl Acad Sci U S A (1999) 1.49
ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. J Physiol (1999) 1.49
Phosphotransfer reactions in the regulation of ATP-sensitive K+ channels. FASEB J (1998) 1.44
ATP-sensitive potassium channels: metabolic sensing and cardioprotection. J Appl Physiol (1985) (2007) 1.43
Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: relevance for cardioplegia. Ann Thorac Surg (1997) 1.43
Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol (1998) 1.42
Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int (2007) 1.37
Bacterial enterotoxins are associated with resistance to colon cancer. Proc Natl Acad Sci U S A (2003) 1.35
Cellular energetics in the preconditioned state: protective role for phosphotransfer reactions captured by 18O-assisted 31P NMR. J Biol Chem (2001) 1.33
Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2A. J Mol Cell Cardiol (1999) 1.30
Ligand-insensitive state of cardiac ATP-sensitive K+ channels. Basis for channel opening. J Gen Physiol (1998) 1.26
Adenylate kinase-catalyzed phosphotransfer in the myocardium : increased contribution in heart failure. Circ Res (1999) 1.24
Failing energetics in failing hearts. Curr Cardiol Rep (2000) 1.24
Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement. EMBO J (2000) 1.23
Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Ther (2010) 1.21
Evidence for direct physical association between a K+ channel (Kir6.2) and an ATP-binding cassette protein (SUR1) which affects cellular distribution and kinetic behavior of an ATP-sensitive K+ channel. Mol Cell Biol (1998) 1.21
Delivery of biologics in cardiovascular regenerative medicine. Clin Pharmacol Ther (2009) 1.21
Stem cells: biologics for regeneration. Clin Pharmacol Ther (2008) 1.14
Inositol 1,4,5-trisphosphate directs Ca(2+) flow between mitochondria and the Endoplasmic/Sarcoplasmic reticulum: a role in regulating cardiac autonomic Ca(2+) spiking. Mol Biol Cell (2000) 1.13
Diazoxide protects mitochondria from anoxic injury: implications for myopreservation. J Thorac Cardiovasc Surg (2001) 1.11
The sulfonylurea controversy: more questions from the heart. J Am Coll Cardiol (1998) 1.10
Reversal of the ATP-liganded state of ATP-sensitive K+ channels by adenylate kinase activity. J Biol Chem (1996) 1.10
Stress without distress: homeostatic role for K(ATP) channels. Mol Psychiatry (2003) 1.10
Compromised energetics in the adenylate kinase AK1 gene knockout heart under metabolic stress. J Biol Chem (2000) 1.09
Structural plasticity of the cardiac nuclear pore complex in response to regulators of nuclear import. Circ Res (1999) 1.07
Burst kinetics of co-expressed Kir6.2/SUR1 clones: comparison of recombinant with native ATP-sensitive K+ channel behavior. J Membr Biol (1997) 1.04
Directed inhibition of nuclear import in cellular hypertrophy. J Biol Chem (2001) 1.02
Induced pluripotent stem cells: an emerging theranostics platform. Clin Pharmacol Ther (2011) 1.00
Operative condition-dependent response of cardiac ATP-sensitive K+ channels toward sulfonylureas. Circ Res (1998) 0.97
K(ATP) channel pharmacogenomics: from bench to bedside. Clin Pharmacol Ther (2007) 0.97
Channelopathies of inwardly rectifying potassium channels. FASEB J (1999) 0.97
Diadenosine 5',5"-P1,P5-pentaphosphate harbors the properties of a signaling molecule in the heart. FEBS Lett (1998) 0.96
Therapeutic targeting: a crucible for individualized medicine. Clin Pharmacol Ther (2008) 0.96
Reduced activity of enzymes coupling ATP-generating with ATP-consuming processes in the failing myocardium. Mol Cell Biochem (1999) 0.95
Increased calcium vulnerability of senescent cardiac mitochondria: protective role for a mitochondrial potassium channel opener. Mech Ageing Dev (2001) 0.95
[Fluorescent analogs of nucleoside-5'-phosphates for the study of nucleic acids by nonradioactive methods]. Mol Biol (Mosk) (1991) 0.95
Gene delivery of Kir6.2/SUR2A in conjunction with pinacidil handles intracellular Ca2+ homeostasis under metabolic stress. FASEB J (1999) 0.94
Molecular medicine hones therapeutic arts to science. Clin Pharmacol Ther (2007) 0.92
Pharmacoproteomics: advancing the efficacy and safety of regenerative therapeutics. Clin Pharmacol Ther (2007) 0.92
Intracellular diadenosine polyphosphates: a novel family of inhibitory ligands of the ATP-sensitive K+ channel. Biochem Pharmacol (1997) 0.92
A disrupter of actin microfilaments impairs sulfonylurea-inhibitory gating of cardiac KATP channels. Am J Physiol (1996) 0.91
Mechanical unloading versus neurohumoral stimulation on myocardial structure and endocrine function In vivo. Circulation (2000) 0.91
Diadenosine polyphosphate-induced inhibition of cardiac KATP channels: operative state-dependent regulation by a nucleoside diphosphate. Pflugers Arch (1996) 0.90
Intracellular acidification and ADP enhance nicorandil induction of ATP sensitive potassium channel current in cardiomyocytes. Cardiovasc Res (1994) 0.90
Low concentrations of 17beta-estradiol protect single cardiac cells against metabolic stress-induced Ca2+ loading. J Am Coll Cardiol (2000) 0.90
Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice. Eur Respir J (2005) 0.89
Reciprocal regulation of expression of pore-forming KATP channel genes by hypoxia. Mol Cell Biochem (2001) 0.89
Clinical pharmacology: the science of therapeutics. Clin Pharmacol Ther (2007) 0.89
Mitochondria: gateway for cytoprotection. Circ Res (2001) 0.89
Use of the MTT assay in adult ventricular cardiomyocytes to assess viability: effects of adenosine and potassium on cellular survival. J Mol Cell Cardiol (1997) 0.89
Spontaneous calcium waves without contraction in cardiac myocytes. Biochem Biophys Res Commun (1995) 0.88
Increased number of cardiomyocytes in cross-sections from tachycardia-induced cardiomyopathic hearts. Int J Mol Med (1999) 0.88
Nuclear transport: target for therapy. Clin Pharmacol Ther (2007) 0.88
Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII gene. J Thromb Haemost (2005) 0.87
Inguinal hernia: measurement of the biomechanics of the lower abdominal wall and the inguinal canal. Hernia (2004) 0.86
Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium. Biochemistry (1999) 0.86
Interruption of transmembrane signaling as a novel antisecretory strategy to treat enterotoxigenic diarrhea. FASEB J (1999) 0.85
Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle. Br J Pharmacol (1993) 0.85
Dual effect of glyburide, an antagonist of KATP channels, on metabolic inhibition-induced Ca2+ loading in cardiomyocytes. Eur J Pharmacol (1996) 0.85
Restoration of Ca2+-inhibited oxidative phosphorylation in cardiac mitochondria by mitochondrial Ca2+ unloading. Mol Cell Biochem (2001) 0.84
KATP channels confer survival advantage in cocaine overdose. Mol Psychiatry (2007) 0.84
Cardiac alpha 1-adrenoceptors mediate positive inotropy via myofibrillar sensitization. Trends Pharmacol Sci (1992) 0.84
[Selection of patients with rectal tumors for local excision based on preoperative diagnosis. Results of a consecutive evaluation study of 552 patients]. Chirurg (2004) 0.84
Systems approaches evolve clinical pharmacology. CPT Pharmacometrics Syst Pharmacol (2013) 0.83
Alpha 1-adrenoceptor and purinoceptor agonists modulate Na-H antiport in single cardiac cells. Am J Physiol (1993) 0.83
Clinical pharmacology as a foundation for translational science. Clin Pharmacol Ther (2011) 0.83
Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J Thorac Cardiovasc Surg (1996) 0.82
Knowledge cycle transforms therapeutic innovation. Clin Pharmacol Ther (2012) 0.82
Alpha-adrenergic regulation of action potentials in isolated rat cardiomyocytes. Eur J Pharmacol (1989) 0.82
Cardiac ATP-sensitive K+ channel: a target for diadenosine 5',5''-P1,P5-pentaphosphate. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.82
Individualized medicine and the imperative of global health. Clin Pharmacol Ther (2007) 0.82
Interruption of Escherichia coli heat-stable enterotoxin-induced guanylyl cyclase signaling and associated chloride current in human intestinal cells by 2-chloroadenosine. J Biol Chem (1997) 0.82
Acquired resistance of a mammalian cell line to hypoxia-reoxygenation through cotransfection of Kir6.2 and SUR1 clones. Lab Invest (1998) 0.82
Comparative analysis of the kinetic characteristics of L-type calcium channels in cardiac cells of hibernators. Biophys J (1996) 0.81
Regulation of potassium channels by G-protein subunits and arachidonic acid metabolites. Methods Enzymol (1994) 0.81
Interpreting networks in systems biology. Clin Pharmacol Ther (2013) 0.81
Advancing pharmacometrics and systems pharmacology. Clin Pharmacol Ther (2012) 0.81
Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. Am J Cardiol (2001) 0.80
Myoplasmic Ca2+ concentration during exertional rhabdomyolysis. Lancet (1995) 0.80
Inhibition of both Na/H and bicarbonate-dependent exchange is required to prevent recovery of intracellular pH in single cardiomyocytes exposed to metabolic stress. Biosci Rep (1999) 0.80